Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: Cancer J. 2012 Jan;18(1):59–68. doi: 10.1097/PPO.0b013e3182431a73

Figure 3.

Figure 3

Approaches to immunotherapy can be divided into passive immunity and active immunity. Passive immunotherapy approaches include direct administration of monoclonal antibodies or cytokines or adoptive immunity with cytotoxic T lymphocytes (CTL) or lymphocyte activated killer (LAK) cells. Active immunity includes peptide based immunotherapy and dendritic cell therapy.